Bml Capital Management, LLC Oramed Pharmaceuticals Inc. Transaction History
Bml Capital Management, LLC
- $124 Billion
- Q1 2025
A detailed history of Bml Capital Management, LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 3,020,748 shares of ORMP stock, worth $6.83 Million. This represents 5.23% of its overall portfolio holdings.
Number of Shares
3,020,748
Previous 2,643,907
14.25%
Holding current value
$6.83 Million
Previous $6.4 Billion
1.03%
% of portfolio
5.23%
Previous 3.97%
Shares
9 transactions
Others Institutions Holding ORMP
# of Institutions
62Shares Held
8.21MCall Options Held
11.2KPut Options Held
200-
Murchinson Ltd. Toronto, A61.75MShares$3.96 Million0.46% of portfolio
-
Boothbay Fund Management, LLC New York, NY845KShares$1.91 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$828,0662.07% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY252KShares$570,0260.61% of portfolio
-
Rathbones Group PLC Liverpool, X0237KShares$535,1740.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $87.7M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...